PLXS

Business Context and Reporting Period

Plexus Corp. is an Electronic Manufacturing Services (EMS) provider offering product realization services to OEMs in sectors including wireline/networking, wireless infrastructure, medical, industrial/commercial, and defense/security/aerospace. This Form 10-Q covers the three and six months ended April 1, 2006 (Fiscal Q2 2006).

Key Financial Metrics

Note: Debt consists of $1.6 million current portion and $21.6 million long-term portion. The company has a $150 million secured revolving credit facility with no borrowings outstanding as of April 1, 2006.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 10.6% ($32.4 million) for the quarter and 12.4% ($73.3 million) for the six months compared to the prior year. Growth was driven by increased demand in wireline/networking, wireless infrastructure, and the addition of a new defense/security/aerospace customer.
• Profitability Turnaround: The company reported a record net income of $18.5 million for the quarter, compared to a net loss of $4.5 million in the prior year quarter. The prior year loss included $10.6 million in restructuring and asset impairment charges.
• Margin Expansion: Gross margins improved to 11.0% (quarter) and 10.3% (six months) from 8.4% and 8.1% respectively in the prior year, driven by operating leverage, favorable customer mix, and the absence of start-up losses at the Penang, Malaysia facility.
• Segment Performance:
  • Asia: Sales surged 87% to $65.0 million; operating income improved to $5.4 million.
  • United States: Sales increased 5% to $242.3 million.
  • Mexico: Sales declined 17% due to a medical customer transferring production to the U.S., though operating loss narrowed.
  • Europe: Sales declined 24% due to reduced demand from a medical customer facing regulatory issues.
• Tax Rate: The effective tax rate dropped to 0% for the quarter and 1% for the six months (vs. 8% prior year) due to tax holidays in Asia and U.S. Net Operating Loss (NOL) carryforwards.

Guidance, Outlook, and Risks

• Full Year Guidance: Management revised full fiscal year 2006 net sales growth target to approximately 20% over fiscal 2005.
• Q3 Outlook: Net sales for the third fiscal quarter are expected to be in the range of $390 million to $405 million. Diluted EPS is expected to be between $0.50 and $0.55, excluding restructuring or impairment costs.
• Capital Allocation: Capital expenditures for fiscal 2006 are estimated at $40 million to $45 million. The company does not anticipate paying cash dividends in the foreseeable future.
• Key Risks:
  • Customer Concentration: Juniper Networks accounted for 20% of sales; General Electric accounted for 11%. The top 10 customers represented 58% of sales.
  • Supply Chain: Risks related to component shortages and price fluctuations in a turnkey manufacturing model.
  • Regulatory: Compliance with FDA regulations for medical devices and EU directives (RoHS and WEEE) regarding hazardous substances and electronic waste.
  • Foreign Operations: Exposure to foreign currency fluctuations and political/economic instability in China, Malaysia, and the UK.

Investor Verification Checklist

• Verify the sustainability of the 20% full-year sales growth target given the heavy reliance on Juniper Networks (20% of sales).
• Monitor the status of the U.S. valuation allowance on deferred tax assets; its reversal would significantly increase the effective tax rate (estimated normalized rate is 25%).
• Assess the impact of the new defense/security/aerospace customer on future revenue stability and margin profiles.
• Review the execution of the Penang, Malaysia facility expansion and its contribution to the Asia segment's profitability.
• Track inventory levels ($207.9 million) relative to sales growth to ensure no obsolescence risks in the turnkey model.